Understanding rare comorbidities in TAVR.
There seems to be an early morbidity and mortality advantage to TAVR in patients with chronic liver disease. Patients with Childs A and B CLD can be treated with TAVR but we know little about TAVR for sicker patients. Technical issues associated with TAVR (the use of transesophageal echocardiography (TEE) for example) have to be weighed in CLD patients with esophageal varices.